Dr. Susan Trapp’s vision is to accelerate cannabis and endocannabinoid research, in a challenging federal environment, through education and research. Dr. Trapp’s segway into the cannabis industry is her extensive terpenoid research background. Susan’s Ph.D. and postdoctoral research examined the molecular evolution of the largest class of plant natural products – TERPENOIDS (terpenes). Susan has been consulting in the cannabis industry for the past several years and in 2018, co-founded an ancillary database cannabis company –TreatmentX – with the mission to advance scientific understanding of cannabis and treatment legitimization through the collation of patient outcomes and cannabis consumption DATA.

Susan has over 20 years of experience in the biotechnology field both as a plant-microbe molecular biology researcher and “beyond the lab bench”. She has held scientific, management, and early-stage development positions within the biotech industry, academia, government, and start-up community, from algae biofuels to genomes. Dr. Trapp participated directly on the human genome project with Dr. Craig Venter early in her scientific career.

Visit us at: https://www.unitedpatientsgroup.com

Follow our Podcast: https://www.buzzsprout.com/1129859

Follow us on Twitter: https://www.twitter.com/upatientsgroup

Facebook: https://www.facebook.com/UnitedPatientsGroup/

source